Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-08

Clinical Trial Update: A Study to Learn About the Taste of Vericiguat Given in Liquid Form in Healthy Male Participants Aged 18 to 45 Years [Phase 1]

View source ↗

Summary

This Phase 1 trial update reports completion of a study assessing the taste of vericiguat in liquid form in healthy adult males, with Heart Failure listed as th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Verquvo (vericiguat)

Snippet

Sponsor: Bayer | Conditions: Heart Failure | Phase 1 | Status: COMPLETED